ELI LILLY & Co (LLY)

788.55 -30.83 (-3.76%)

As of 2025-10-16 22:20:29 EST

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

Traded asNYSE: LLY
ISINUS5324571083
CIK0000059478
LEIFRDRIPF3EKNDJ2CQJL29
EIN350470950
SectorPharmaceutical
IndustryPharmaceutical Preparations
CEODavid A. Ricks
Employees47,000
Fiscal Year End1231
AddressLILLY CORPORATE CTR, INDIANAPOLIS, IN, 46285
Phone3172762000
Websitehttps://www.lilly.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
LLYELI LILLY & Co2025-10-16 22:20:29788.55-30.83-3.76
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
LLY0000059478ELI LILLY & CoUS5324571083FRDRIPF3EKNDJ2CQJL29350470950NYSE2834Pharmaceutical Preparations1231INLILLY CORPORATE CTRINDIANAPOLISIN46285UNITED STATESUS3172762000LILLY CORPORATE CENTER, INDIANAPOLIS, IN, 46285LILLY CORPORATE CTR, INDIANAPOLIS, IN, 46285LILLY ELI & COPharmaceutical1876David A. Ricks47,000https://www.lilly.com/769,792,000,000947,903,000946,456,759Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.2025-10-10 18:59:56
This is a preview of the latest data. Subscribe to access the full data.
LLY Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
LLY Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024769,792,000,000371,501,000,00093.2738948,169,999-1,994,453-0.2099
2023398,291,000,000123,949,000,00045.1805950,164,452-131,666-0.0139
2022274,342,000,00080,693,000,00041.6697950,296,118-2,051,008-0.2154
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Daniel M. Skovronsky, M.D.Chief Scientific Officer, President, Executive Vice President20241,430,76907,499,8953,219,230206,98012,638,744
Anat HakimSecretary, Executive Vice President, General Counsel20241,000,00003,950,0712,250,00066,8347,478,426
David A. RicksChair, Chief Executive Officer, President20241,690,385019,749,3245,705,049351,68529,242,926
Lucas MontarceChief Financial Officer, Executive Vice President2024664,63901,067,1351,114,55839,8782,948,519
Jake Van NaardenPresident, Executive Vice President2024890,38502,700,2482,003,366113,0625,773,948
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202447,000
202343,000
202239,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue45,042,700,00034,124,100,00028,541,400,000
Cost Of Revenue8,418,300,0007,082,200,0006,629,800,000
Gross Profit———
Research And Development Expenses10,990,600,0009,313,400,0007,190,800,000
General And Administrative Expenses8,593,800,0007,403,100,0006,440,400,000
Operating Expenses———
Operating Income———
Net Income10,590,000,0005,240,400,0006,244,800,000
Earnings Per Share Basic11.765.826.93
Earnings Per Share Diluted11.715.86.9
Weighted Average Shares Outstanding Basic900,605,000900,181,000901,736,000
Weighted Average Shares Outstanding Diluted904,059,000903,284,000904,619,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents3,268,400,0002,818,600,0002,067,000,000
Marketable Securities Current154,800,000109,100,000144,800,000
Accounts Receivable11,005,700,0009,090,500,0006,896,000,000
Inventories7,589,200,0005,772,800,0004,309,700,000
Non Trade Receivables——1,662,900,000
Other Assets Current111,400,000149,500,000—
Total Assets Current32,739,700,00025,727,000,00018,034,500,000
Marketable Securities Non Current3,215,900,0003,052,200,0002,901,800,000
Property Plant And Equipment17,102,400,00012,913,600,00010,144,000,000
Other Assets Non Current5,719,700,0004,989,900,0001,871,800,000
Total Assets Non Current18,765,400,00014,500,000,00011,234,100,000
Total Assets78,714,900,00064,006,300,00049,489,800,000
Accounts Payable3,228,600,0002,598,800,0001,930,600,000
Deferred Revenue———
Short Term Debt5,117,100,0006,904,500,0001,501,100,000
Other Liabilities Current5,051,400,0003,281,300,0002,370,300,000
Total Liabilities Current28,376,600,00027,293,200,00017,138,200,000
Long Term Debt29,474,000,00019,104,600,00014,815,300,000
Other Liabilities Non Current2,178,200,0002,240,600,0001,736,700,000
Total Liabilities Non Current36,066,700,00025,849,400,00021,576,200,000
Total Liabilities64,443,300,00053,142,600,00038,714,400,000
Common Stock592,400,000593,600,000594,100,000
Retained Earnings13,545,000,00010,312,300,00010,042,600,000
Accumulated Other Comprehensive Income-4,321,900,000-4,327,000,000-3,844,600,000
Total Shareholders Equity14,192,100,00010,771,900,00010,649,800,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization1,766,600,0001,527,300,0001,522,500,000
Share Based Compensation Expense645,600,000628,500,000371,100,000
Other Non Cash Income Expense———
Change In Accounts Receivable2,155,200,0002,451,000,000299,600,000
Change In Inventories2,507,400,0001,425,000,000599,700,000
Change In Non Trade Receivables———
Change In Other Assets—3,453,400,000793,500,000
Change In Accounts Payable2,608,800,0004,274,400,0001,331,700,000
Change In Other Liabilities———
Cash From Operating Activities8,817,900,0004,240,100,0007,084,400,000
Purchases Of Marketable Securities98,500,00098,200,000107,400,000
Sales Of Marketable Securities148,900,000192,200,000121,400,000
Acquisition Of Property Plant And Equipment5,057,800,0003,447,600,0001,854,300,000
Acquisition Of Business——327,200,000
Other Investing Activities298,200,000191,900,000206,400,000
Cash From Investing Activities-9,301,500,000-7,152,700,000-3,261,600,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends4,680,400,0004,069,300,0003,535,800,000
Issuance Of Common Stock———
Repurchase Of Common Stock2,500,000,000750,000,0001,500,000,000
Issuance Of Long Term Debt11,417,100,0003,958,500,0000
Repayment Of Long Term Debt664,200,00001,560,000,000
Other Financing Activities-490,600,000-335,000,000-308,900,000
Cash From Financing Activities1,230,100,0003,495,600,000-5,406,700,000
Change In Cash449,800,000751,600,000-1,751,500,000
Cash At End Of Period3,268,400,0002,818,600,0002,067,000,000
Income Taxes Paid6,562,100,0005,558,800,0002,672,900,000
Interest Paid577,500,000404,200,000323,700,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share11.765.826.93
Price To Earnings Ratio65.6463100.158152.7908
Earnings Growth Rate102.0619-16.017312.6829
Price Earnings To Growth Ratio0.6432-6.25314.1623
Book Value Per Share15.846712.068411.9496
Price To Book Ratio48.716848.301530.6152
Ebitda19,699,300,00012,812,400,00010,771,800,000
Enterprise Value726,589,760,000547,924,008,520344,140,498,240
Dividend Yield0.00670.00780.0107
Dividend Payout Ratio0.4420.77650.5662
Debt To Equity Ratio2.43732.41451.5321
Capital Expenditures5,955,400,0004,296,900,0002,681,400,000
Free Cash Flow2,862,500,000-56,800,0004,403,000,000
Return On Equity0.74620.48650.5864
One Year Beta0.87510.44080.5337
Three Year Beta0.57050.5170.6654
Five Year Beta0.66150.64790.6753
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
LILLY ENDOWMENT INC10% owner2025-10-10468D94,536,510
LILLY ENDOWMENT INC10% owner2025-10-103,190D94,533,320
LILLY ENDOWMENT INC10% owner2025-10-09600D94,546,980
LILLY ENDOWMENT INC10% owner2025-10-09400D94,546,580
LILLY ENDOWMENT INC10% owner2025-10-093,375D94,543,205
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Markwayne MullinSenator2025-08-12Purchase2024-12-11Joint$50,001 - $100,000
Thomas H TubervilleSenator2025-05-15Sale (Full)2025-04-15Joint$15,001 - $50,000
Ron L WydenSenator2025-02-21Sale (Full)2025-02-10Spouse$50,001 - $100,000
Ron L WydenSenator2025-02-21Purchase2025-01-22Spouse$50,001 - $100,000
Sheldon WhitehouseSenator2024-11-07Purchase2024-10-30Self$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Valerie Hoyle2025-10-10OR04Sale2025-09-23Spouse$1,001 - $15,000
Valerie Hoyle2025-09-12OR04Purchase2024-10-29Spouse$1,001 - $15,000
Valerie Hoyle2025-09-12OR04Sale (Partial)2025-05-06Spouse$1,001 - $15,000
Julie Johnson2025-09-11TX32Sale (Partial)2025-08-14Joint$1,001 - $15,000
David J. Taylor2025-09-02OH02Purchase2025-08-14—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Bill Few Associates, Inc.2025-09-301,725,1432,261763
LOCKERMAN FINANCIAL GROUP, INC.2025-09-30470,410617762.4149
WILLNER & HELLER, LLC2025-09-30713,972936762.7906
Carnegie Investment Counsel2025-09-309,486,95812,434762.9852
AMI INVESTMENT MANAGEMENT INC2025-09-30226,611297763
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Jensen Quality Growth Fund Inc2025-08-31Y SharesJENYX279,000204,389,8203.5261
Jensen Quality Growth Fund Inc2025-08-31R SharesJENRX279,000204,389,8203.5261
Jensen Quality Growth Fund Inc2025-08-31I SharesJENIX279,000204,389,8203.5261
Jensen Quality Growth Fund Inc2025-08-31J SharesJENSX279,000204,389,8203.5261
CAPITAL MANAGEMENT INVESTMENT TRUST2025-08-31Institutional SharesWSACX2,6001,904,7083.04
This is a preview of the latest data. Subscribe to access the full data.